Neostigmine Methylsulfate 65219-0811
Product NDC
65219-0811- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- January 8, 2015
- Listing Expires
- December 31, 2026
- Application
- NDA203629
Need to source Neostigmine Methylsulfate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Neostigmine Methylsulfate | 1 mg/mL |
Drug Class
Cholinesterase Inhibitor [EPC]Cholinesterase Inhibitors [MoA]
Packaging Options(1)
10 VIAL, MULTI-DOSE in 1 TRAY (65219-811-10) / 10 mL in 1 VIAL, MULTI-DOSE (65219-811-01)